MENU
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genmab A/S ADS (GMAB) Ownership - Who owns Genmab A/S ADS?

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more

Profile

Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.69B
P/E Ratio
10.07
Total Cash
21.1B
Projected Growth
0.98
Total Debt
1.03B
Revenue
21.53B
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
33.48
Total Debt/Equity
N/A
Revenue/Share
4.90 USD as % of share price

Fundamentals

GMAB
Capitalization
11.7B
P/E Ratio
10.07
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
21.1B
Total Cash/Share
33.48
Total Debt
1.03B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.98
Revenue/Share (as % of the share price)
4.90%
Revenue
21.5B
ROE
N/A
Book Value
36.7B
P/B Ratio
2.10
Cash Flow
N/A
Earnings
12.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66M
Current Ratio
5.25
Current Revenue Per Employee
2401566.00
Dividends Per Share - Security
N/A
EBITDA
9.7B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.77
Revenue To Assets
19.34
Shares Held By Institutions
18.9B
Shares Outstanding - Current
630M
Total Liabilities
9.11B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-9.775
View a ticker or compare two or three
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com